Rachael L. Sumner

85 Park Road
Grafton, AUK 1023, New Zealand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

General Anesthesia and Discrete Components of Ketamine Neurophysiology.

General Anesthesia and Discrete Components of Ketamine Neurophysiology.

Journal: JAMA psychiatry
Published: April 08, 2026

An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.

An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.

Journal: Pharmacology
Published: January 21, 2026

Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study.

Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study.

Journal: Frontiers in pharmacology
Published: December 14, 2025

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 02, 2025

Predictive coding and neurocomputational psychiatry: a mechanistic framework for understanding mental disorders.

Predictive coding and neurocomputational psychiatry: a mechanistic framework for understanding mental disorders.

Journal: Frontiers in psychiatry
Published: September 26, 2025

Scopolamine's Anticholinergic Effects on EEG Spectral, Aperiodic, Complexity, Microstates, and Heart Rate Variability.

Scopolamine's Anticholinergic Effects on EEG Spectral, Aperiodic, Complexity, Microstates, and Heart Rate Variability.

Journal: Human psychopharmacology
Published: June 03, 2025

Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers.

Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers.

Journal: Journal of psychopharmacology (Oxford, England)
Published: April 19, 2025

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.

Journal: Therapeutic advances in psychopharmacology
Published: April 02, 2025

The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis.

The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis.

Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: December 11, 2024

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Journal: Neuropharmacology
Published: November 28, 2024

LSD microdosing in major depressive disorder: results from an open-label trial.

LSD microdosing in major depressive disorder: results from an open-label trial.

Journal: Neuropharmacology
Published: November 18, 2024

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Journal: Trials
Published: April 18, 2024
Showing 1-12 of 44

Last Updated: 09/26/2026